FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved NIVESTYM (filgrastim-aafi) in a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia Due to Cancer Chemotherapy

Drugs mentioned

• NIVESTYM (FILGRASTIM-AAFI)

Snippet

SUPPL AP for NIVESTYM (FILGRASTIM-AAFI)